Evaluation of chemagic™ 360 with the Applied BioCode Gastrointestinal Pathogen Panel (GPP) and Respiratory Pathogen Panel (RPP) with the MDx-3000 Molecular Diagnostic System
Time: 11 am EST, April 4th, 2024
Speaker Bio: Beth Laderman, Ph.D.
Dr. Laderman was educated at The Johns Hopkins University, where she received her undergraduate degree in Biology, and at The University of California, Los Angeles’ David Geffen School of Medicine, where she received her Ph.D. in the Department of Biological Chemistry. Dr. Laderman has over 25 years of experience in biopharmaceutical, medical diagnostic, and lab service fields, with experience at Baxter BioScience, Focus Diagnostics (formerly a part of Quest and now a part of Diasorin Molecular, LLC), MDxHealth, Biomerica, and Hycor Biomedical, among others. With a broad range of experience in product development, technical operations, quality and regulatory, and clinical trials, Dr. Laderman has brought a wide range of IVD products to market in the US, EMEA, and APAC spheres.
Learning Objectives
- How automation address challenges in medium to high throughput sample preparation from diverse human matrices.
- See how automation with chemagic™ 360 instrument is being performed for testing the BioCode highly multiplexed Respiratory and Gastrointestinal Pathogen Panels with Applied BioCode MDx-3000.
- See how the chemagic™ 360 instrument is being evaluated and compared using the BioCode multiplexed Respiratory and Gastrointestinal Pathogen Panels.
- Key issues to address when setting up and choosing an automated workflow for your lab.